13 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

FRESENIUS OPTIFLUX 200A

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

GEN4 Direct Access

FDA UDI
CURBELL MEDICAL PRODUCTS, INC.·00840828107563·GEN4 Direct Access

MAMMARY IMPLANT

FDA Adverse Event
Injury ·DOW CORNING CORP.·Product code FTR·September 23, 1994

THE FUGO BLADE

FDA 510(k)
FDA Class 2 ·Ophthalmic

COHERENT LASERLINK Z-1000 SLIT LAMP LASER DELIVERY ADAPTER

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

LIFEVEST WCD 4000 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·February 11, 2013

HOMECHOICE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - LARGO·Product code FKX·March 1, 2011

CLEARSTAR PUMP

FDA Adverse Event
Malfunction ·ROSS PRODUCTS DIVISION·Product code LZH·February 21, 2008

LIFEWISE BLOOD PRESSURE MONITOR

FDA Adverse Event
Injury ·RADIOSHACK·Product code DXN·October 20, 2004

BAXJECT II HI-FLOW NEEDLESS TRANSFER DEVICE

FDA Adverse Event
Malfunction ·TAKEDA PHARMACEUTICALS U.S.A., INC.·Product code LHI·May 4, 2026

smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

LapSac Surgical Tissue Pouch. The current intended use for the LapSac Surgical Tissue Pouch is for isolating tissue during, or prior to, surgical removal and/or morcellation. The device is a reinforced pouch with an inner liner and drawstring closure. The device may be used to isolate tissue and/or act as a containment system during surgery. It is provided in a variety of sizes and has applications in the Urology, Surgery, and Reproductive Health business units.

FDA Enforcement
Class II ·Terminated·Cook Inc.·July 1, 2015

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024